Recent Finacing
Recent Raise
Rebel Medicine develops proprietary injectable drug-delivery platforms to extend validated APIs' duration, including Alevatrix, a bupivacaine formulation releasing drug up to 72 hours, with an IND and planned Phase 2.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Rebel Medicine.
